Aquilo Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,573
| Closed | -$29K | – | 13 |
|
|
2022
Q3 | $29K | Sell |
3,573
-858,034
| -100% | -$6.96M | 0.01% | 14 |
|
|
2022
Q2 | $6.01M | Sell |
861,607
-893,899
| -51% | -$6.24M | 2.05% | 11 |
|
|
2022
Q1 | $26.5M | Buy |
1,755,506
+245,562
| +16% | +$3.71M | 3.9% | 7 |
|
|
2021
Q4 | $33.1M | Buy |
1,509,944
+410,000
| +37% | +$9M | 3.76% | 6 |
|
|
2021
Q3 | $29.7M | Buy |
1,099,944
+154,562
| +16% | +$4.17M | 5.39% | 7 |
|
|
2021
Q2 | $22.8M | Buy |
945,382
+644,496
| +214% | +$15.5M | 5.92% | 9 |
|
|
2021
Q1 | $13.1M | Buy |
300,886
+280,886
| +1,404% | +$12.2M | 2.36% | 10 |
|
|
2020
Q4 | $829K | Buy |
+20,000
| New | +$829K | 0.17% | 15 |
|